Benign total abdominal hysterectomy Local infiltration, Benign total abdominal hysterectomy
Conditions
Interventions
0.5%Bupivacaine 100 mg+ Dexamethasone 8mg (2ml) local infiltration before skin closure,0.5%Bupivacaine 100 mg+ NSS 2 ml local infiltration before skin closure
Experimental Drug,Placebo Comparator Drug
Sponsors
None listed
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Woman age 18-65 years 2.Patients scheduled for elective benign total abdominal hysterectomy surgery under geneal anesthesia 3.BW >50 kg 4.ASA physical status I-II
Exclusion criteria
Exclusion criteria: 1.Allergy Bupivacaine or another local anesthetic drug amide group 2.Allergy Dexamethasone 3.Severe underlying disease such as CKD stage 3 or more, severe heart disease, poor control DM and active or chronic liver disease and asthma poor control 4.Cannot understand Thai 5.Malignancy 6.intraoperative complication such as bowel injury
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score at 12 hours post operative operation 12 hour post operative Visual analog scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score after 2 hours post operation 2 hour post operative Visual analog scale (mean),Pain score after 6 hours post operation 12 hour postoperative Visual analog scale (mean),Pain score after 18 hours postoperation 18 hour postoperative Visual analog scale (mean),Pain score after 24 hours postoperation 24 hour postoperative Visual analog scale (mean),Rescue morphine 24 hour postoperative Mg (mean),Postoperative nausea vomit 24 hour postoperative N%,Patient satisfaction score Before dischage Mean,Surgical wound complication Before dischage N% | — |
Countries
Thailand
Contacts
Public ContactNathchakan Dansai
Khon Kaen hospital
Outcome results
None listed